Makers Laboratories Ltd

Makers Labs. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Makers Laboratories Ltd

₹ 150 0.37%
22 Jul - close price
makerslabs.com BSE: 506919
About

Incorporated in 1984, Makers Laboratories
Ltd is in the business of manufacturing and marketing of pharmaceuticals

Key Points

Business Overview:[1][2][3]
The company markets 200+ generic formulations in India across major therapeutic segments like anti-malarial, antibiotics, anti-inflammatory, analgesics, and anti-diabetics, catering to dispensing doctors, nursing homes, and hospitals. It also undertakes job work for injectables (anti-malarial) for IPCA and procures products on a P2P basis from manufacturers in Himachal Pradesh and Uttarakhand's excise-free zones.

Website BSE
  • Market Cap ₹ 88.5 Cr.
  • Current Price ₹ 150
  • High / Low ₹ 230 / 122
  • Stock P/E 39.4
  • Book Value ₹ 120
  • Dividend Yield 0.00 %
  • ROCE 4.25 %
  • ROE 3.36 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.

Cons

  • Company has a low return on equity of -2.44% over last 3 years.
  • Earnings include an other income of Rs.10.9 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
27.29 25.45 26.50 19.88 29.45 25.01 25.06 26.51 27.81 29.59 29.57 27.69 33.90
25.25 25.44 24.87 20.06 27.66 25.15 24.86 26.31 26.95 27.78 27.38 26.38 30.81
Operating Profit 2.04 0.01 1.63 -0.18 1.79 -0.14 0.20 0.20 0.86 1.81 2.19 1.31 3.09
OPM % 7.48% 0.04% 6.15% -0.91% 6.08% -0.56% 0.80% 0.75% 3.09% 6.12% 7.41% 4.73% 9.12%
0.62 1.01 0.88 0.27 0.12 0.25 0.41 0.37 0.43 -0.51 10.63 0.87 0.10
Interest 0.41 0.39 1.07 0.42 0.25 0.41 0.49 0.53 0.52 0.49 0.43 0.19 0.18
Depreciation 0.99 0.89 1.03 1.19 1.13 1.11 1.13 1.16 1.15 1.28 1.29 1.31 0.90
Profit before tax 1.26 -0.26 0.41 -1.52 0.53 -1.41 -1.01 -1.12 -0.38 -0.47 11.10 0.68 2.11
Tax % 26.98% 219.23% 82.93% 17.11% 33.96% 18.44% 10.89% -4.46% 152.63% 48.94% 11.98% 60.29% 24.64%
0.93 -0.83 0.07 -1.78 0.35 -1.66 -1.13 -1.06 -0.97 -0.70 9.76 0.27 1.58
EPS in Rs -1.03 -2.75 -1.08 -3.75 -0.47 -3.56 -2.27 -2.61 -2.19 -1.66 14.95 -0.51 -0.08
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
69 127 101 104 121
60 108 98 103 112
Operating Profit 8 19 3 1 9
OPM % 12% 15% 3% 1% 7%
1 3 2 2 11
Interest 2 2 2 2 1
Depreciation 5 4 4 5 5
Profit before tax 3 16 -1 -4 13
Tax % 50% 25% 161% 23% 19%
1 12 -2 -5 11
EPS in Rs -0.56 8.44 -8.05 -10.61 12.69
Dividend Payout % 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: -2%
TTM: 16%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -23%
TTM: 146%
Stock Price CAGR
10 Years: 9%
5 Years: 20%
3 Years: -2%
1 Year: 11%
Return on Equity
10 Years: %
5 Years: %
3 Years: -2%
Last Year: 3%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 5 5 6 6 6
Reserves 49 55 63 57 65
21 23 17 22 8
62 62 66 76 70
Total Liabilities 136 144 152 161 148
71 68 85 87 74
CWIP 0 9 0 0 1
Investments 2 0 0 3 0
63 66 67 71 73
Total Assets 136 144 152 161 148

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0 18 -9 1 -4
0 -22 1 -7 20
0 0 6 6 -16
Net Cash Flow 0 -3 -2 -0 -0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 88 39 72 70 84
Inventory Days 344 166 281 227 230
Days Payable 182 38 91 112 79
Cash Conversion Cycle 250 167 262 185 234
Working Capital Days 159 104 139 128 145
ROCE % 15% 1% -2% 4%

Shareholding Pattern

Numbers in percentages

Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.39% 0.39% 0.39%
38.73% 38.73% 38.72% 38.73% 38.73% 38.74% 38.73% 38.74% 38.73% 38.33% 38.34% 38.35%
No. of Shareholders 4,8394,6214,4834,4024,2834,1794,1764,0904,0084,0314,1354,073

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Right Issue

Credit ratings